Neuroscience

Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
A3599 MetoclopramideSummary: Dopamine receptor antagonist -
A3612 MK-0974Target: CGRP receptorsSummary: CGRP receptor antagonist -
A1295 Granisetron HClSummary: 5-HT3 receptor antagonist -
A1450 LidocaineTarget: Histamine H1 ReceptorsSummary: Anasthetic and class Ib antiarrhythmic agent -
A1958 EtomidateTarget: GABAA ReceptorsSummary: General anesthetic with GABA modulatory and GABA-mimetic actions -
A1664 CelecoxibTarget: COXSummary: Selective cyclooxygenase-2 (COX-2) inhibitor -
A1607 PrasugrelSummary: ADP receptor inhibitor -
A1366 Rocuronium BromideSummary: TGF-βR I kinase inhibitor -
A1684 AprepitantTarget: Substance P/NK1 ReceptorSummary: Substance P (SP) inhibitor -
A2623 VU 0364439Summary: Positive allosteric mGluR-4 modulator
